Dyne Therapeutics Inc. (DYN)
26.11
+0.13 (0.50%)
Upcoming Events
Latest Headlines
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 20, 2026 4:05 PM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: Aug 13 Filed by: Rhodes Jason P
August 17, 2026 5:30 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Aug 13 Filed by: Friedl-Naderer Johanna
August 17, 2026 4:09 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Aug 13 Filed by: Kerr Douglas
August 17, 2026 4:08 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Aug 13 Filed by: Cox John
August 17, 2026 4:07 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Aug 13 Filed by: Lucera Erick
August 17, 2026 4:06 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Dyne Therapeutics (DYN)
August 17, 2026 6:42 AM - StreetInsider
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
August 14, 2026 5:48 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
August 14, 2026 5:48 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
August 14, 2026 5:47 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
August 13, 2026 5:37 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
August 13, 2026 5:36 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
August 13, 2026 5:36 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Cox John
August 13, 2026 5:04 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Lucera Erick
August 13, 2026 5:04 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Kerr Douglas
August 13, 2026 5:03 PM - SEC Filing
Form SCHEDULE 13G/A Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
August 13, 2026 4:52 PM - SEC Filing
Form SCHEDULE 13G/A Dyne Therapeutics, Inc. Filed by: Janus Henderson Group Ltd.
August 13, 2026 12:47 PM - SEC Filing
Form SCHEDULE 13G/A Dyne Therapeutics, Inc. Filed by: FMR LLC
August 6, 2026 10:21 AM - SEC Filing
Dyne Therapeutics (DYN) PT Lowered to $45 at Morgan Stanley
July 31, 2026 8:00 AM - StreetInsider
Dyne Therapeutics (DYN) PT Raised to $35 at RBC Capital
July 30, 2026 8:33 AM - StreetInsider
Dynegy (DYN) Misses Q2 EPS by 33c
July 29, 2026 5:49 PM - StreetInsider
Form 8-K Dyne Therapeutics, Inc. For: Jul 29
July 29, 2026 4:35 PM - SEC Filing
Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
July 29, 2026 4:30 PM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: Jul 27 Filed by: Kersten Dirk
July 29, 2026 4:15 PM - SEC Filing
Form 10-Q Dyne Therapeutics, Inc. For: Jun 30
July 29, 2026 4:06 PM - SEC Filing
Form SCHEDULE 13G/A Dyne Therapeutics, Inc. Filed by: BlackRock, Inc.
July 28, 2026 4:45 PM - SEC Filing
FDA clears Dyne Therapeutics IND for DYNE-302 in rare muscle disease
July 28, 2026 7:32 AM - StreetInsider
Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)
July 28, 2026 7:30 AM - StreetInsider
Form 144 Dyne Therapeutics, Inc. Filed by: ForDyne B.V.
July 27, 2026 4:20 PM - SEC Filing
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 24, 2026 4:05 PM - StreetInsider
Dyne Therapeutics closes $431.4M public stock offering
July 23, 2026 4:05 PM - StreetInsider
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
July 23, 2026 4:05 PM - StreetInsider
Cantor Fitzgerald Starts Dyne Therapeutics (DYN) at Overweight
July 23, 2026 6:24 AM - StreetInsider
Form 424B5 Dyne Therapeutics, Inc.
July 22, 2026 5:21 PM - SEC Filing
Form 8-K Dyne Therapeutics, Inc. For: Jul 21
July 22, 2026 5:20 PM - SEC Filing
Dyne Therapeutics prices $375M public stock offering at $20.50
July 21, 2026 10:46 PM - StreetInsider
Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock
July 21, 2026 10:46 PM - Globe NewsWire
Form 424B5 Dyne Therapeutics, Inc.
July 21, 2026 5:22 PM - SEC Filing
Dyne Therapeutics launches $300M common stock offering
July 21, 2026 4:47 PM - StreetInsider
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
July 21, 2026 4:46 PM - Globe NewsWire
Dyne Therapeutics (DYN) PT Raised to $47 at Piper Sandler
July 20, 2026 11:29 AM - StreetInsider
Form 8-K Dyne Therapeutics, Inc. For: Jul 20
July 20, 2026 7:35 AM - SEC Filing
FDA accepts Dyne Therapeutics BLA for DMD drug z-rostudirsen
July 20, 2026 7:30 AM - StreetInsider
Dyne Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
July 20, 2026 7:30 AM - StreetInsider
Dyne Therapeutics Inc. (DYN) call put ratio 1.1 calls to 1 put as share price down 1.5%
July 13, 2026 2:32 PM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: Jul 06 Filed by: Rhodes Jason P
July 8, 2026 5:35 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
July 7, 2026 5:07 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
July 7, 2026 5:06 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
July 7, 2026 5:06 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
July 7, 2026 5:06 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
July 6, 2026 5:17 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
July 6, 2026 5:17 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
July 6, 2026 5:17 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 26 Filed by: Rhodes Jason P
June 30, 2026 7:05 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
June 29, 2026 5:51 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
June 29, 2026 5:50 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
June 29, 2026 5:50 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
June 26, 2026 5:05 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
June 26, 2026 5:04 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
June 26, 2026 5:04 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 25 Filed by: Lucera Erick
June 26, 2026 4:15 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 23 Filed by: Rhodes Jason P
June 26, 2026 8:40 AM - SEC Filing
TD Cowen Starts Dyne Therapeutics (DYN) at Buy
June 26, 2026 5:51 AM - StreetInsider
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
June 25, 2026 5:29 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
June 25, 2026 5:29 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
June 25, 2026 5:29 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Lucera Erick
June 25, 2026 5:11 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
June 24, 2026 5:36 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
June 24, 2026 5:34 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
June 24, 2026 5:33 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 22 Filed by: Kersten Dirk
June 24, 2026 4:27 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
June 23, 2026 6:26 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
June 23, 2026 6:25 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
June 23, 2026 6:20 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 22 Filed by: Greene Barry E
June 23, 2026 4:07 PM - SEC Filing
Form 3 Dyne Therapeutics, Inc. For: Jun 22 Filed by: Greene Barry E
June 23, 2026 4:05 PM - SEC Filing
Form 8-K Dyne Therapeutics, Inc. For: Jun 22
June 22, 2026 4:16 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 17 Filed by: Kersten Dirk
June 22, 2026 4:15 PM - SEC Filing
Dyne Therapeutics adds Barry Greene to its board of directors
June 22, 2026 4:10 PM - StreetInsider
Dyne Therapeutics Appoints Barry Greene to Board of Directors
June 22, 2026 4:10 PM - StreetInsider
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 18, 2026 4:05 PM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: Jun 16 Filed by: Kerr Douglas
June 17, 2026 4:09 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 16 Filed by: Friedl-Naderer Johanna
June 17, 2026 4:08 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 16 Filed by: Cox John
June 17, 2026 4:07 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: ForDyne B.V.
June 17, 2026 4:05 PM - SEC Filing
Form 8-K Dyne Therapeutics, Inc. For: Jun 16
June 17, 2026 7:35 AM - SEC Filing
Dyne Therapeutics expands debt facility to $400M with Hercules Capital
June 17, 2026 7:30 AM - StreetInsider
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.
June 17, 2026 7:30 AM - StreetInsider
Form 144 Dyne Therapeutics, Inc. Filed by: Cox John
June 16, 2026 4:11 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 05 Filed by: HURWITZ EDWARD
June 9, 2026 5:16 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 05 Filed by: Lubner David Charles
June 9, 2026 5:14 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 05 Filed by: Rhodes Jason P
June 9, 2026 5:13 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 05 Filed by: Kersten Dirk
June 9, 2026 5:13 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 05 Filed by: Incerti Carlo
June 9, 2026 5:12 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 05 Filed by: Stehman-Breen Catherine
June 9, 2026 5:09 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 05 Filed by: Posner Brian S
June 9, 2026 5:06 PM - SEC Filing
Form 8-K Dyne Therapeutics, Inc. For: Jun 05
June 8, 2026 4:05 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 03 Filed by: Posner Brian S
June 5, 2026 4:10 PM - SEC Filing
Form 8-K Dyne Therapeutics, Inc. For: Jun 03
June 3, 2026 7:35 AM - SEC Filing
Dyne Therapeutics completes enrollment in myotonic dystrophy trial
June 3, 2026 7:30 AM - StreetInsider
Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)
June 3, 2026 7:30 AM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: May 26 Filed by: Posner Brian S
May 28, 2026 4:56 PM - SEC Filing
Dyne Therapeutics submits FDA application for DMD treatment
May 26, 2026 7:31 AM - StreetInsider
Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
May 26, 2026 7:30 AM - StreetInsider
Full Article List
